Nordic Life Science 1
BUSINE S S CELLINK Life Sciences has changed name
to BICO (BIo COnvergence) while maintaining the CELLINK name for the bioprinting business. THE GROUP HAS transformed itself to create a more growth-oriented business structure for faster life science innovations, it states. The name has been changed to better reflect the new structure and all the opportunities that lie within. The company will be focused around five central areas, including the enabling of safer and accessible organ transplants, utilization of cultivated tissue from human cells to eliminate unnecessary animal testing, faster development of more affordable medicines, more personalized medicines, and faster and less expensive diagnostics to fight infectious diseases. The subsidiaries that are a part of BICO will keep their names and operate as individual companies. The company’s ticker has been updated from CLNK to BICO. Erik Gatenholm, CEO, BICO